Med-X, Inc. Positions Nature-Cide for World-Wide Growth
LOS ANGELES, March 16, 2018 /-- Med-X, Inc. ("Med-X") today announced that Adamarie Wilson has been appointed Vice President of Sales for the Nature-Cide Division. Ms. Wilson comes to the Company with a 20-year track record in the pest control industry, with her last position spanning over five years at Target Specialty Products. The Nature-Cide Division has had significant growth within Target Specialty Products and its sister company Residex distribution outlets under Ms. Wilson's supervision.
"I was initially introduced to the Nature-Cide brand and its line of products in 2015, as the brand had seemingly become a social media sensation amongst pest control professionals on Facebook, LinkedIn, Twitter and Instagram. I knew I had to get involved in the brand's growth," states Ms. Wilson. In 2016 and 2017 Ms. Wilson oversaw Nature-Cide's positioning throughout the United States as well as testing protocols in Hong Kong, Macau, and Mumbai by Target Specialty Products parent company Rentokil Initial. Matthew Mills, President of Med-X, Inc. stated: "We are very excited to turn the Nature-Cide reins over to Ms. Wilson, as we are very confident in her efforts to continue to lead and position Nature-Cide products around the world."
Over the last two years, the Nature-Cide team has been working with multiple distribution representatives in the United States and Asia and has garnered a vast professional services customer base. There is a constant and increased demand by consumers for environmentally friendly products and an aversion and lack of acceptance for the tainted traditional pest control application products of the past. "Our Nature-Cide products are used in the home, hotel rooms, grocery stores, transportation venues, parks, and zoos. Today's consumers have become increasingly educated about health concerns related to potentially toxic pesticides and their applications, and the public is demanding immediate change," states Dr. David Toomey, Chief Executive Officer, Med-X, Inc.
According to Dr. Toomey, this increased demand for healthy change has had development service teams at Nature-Cide working side by side with commercial customers from around the world. The R&D that has been performed with the Nature-Cide product line has led to the development of non-toxic, pleasantly aromatic and highly effective products. "Our product is innovative in that it is free from the pungent odors normally associated with both traditional and natural products from the past. This has been achieved by using cutting-edge blending techniques which have led our development team to meet and exceed our expectations," states Toomey.
The vast commercial pest control and turf care customer base of Target Specialty Products contains a host of professional applicators. Pest control products are commonly used in settings such as consumer food plants, hotels & resorts, medical facilities, parks & recreation centers, schools, the transportation arena, and numerous residential venues. Many consumers, in all areas of life, will experience favorable long-term results with Nature-Cide and the Nature-Cide application methods. Both Nature-Cide and Target Specialty Products management teams are strategizing and working together in a "Green Scene" initiative to meet the pressing demand of the public and lawmakers worldwide. "We are excited to have Nature-Cide products as part of our Green initiatives for 2018 and beyond," states Todd Ferguson, President of Target Specialty Products.
About Med-X, Inc.
Med-X, Inc. is a Nevada corporation formed in February 2014 which through its wholly owned subsidiary Pacific Shore Holdings, Inc. produces various products such as the all-natural Nature-Cide pest control products that have evolved from its Nature-Cide Pest Management Service division. Pacific Shore Holdings, Inc. is also known for its patented and clinically proven Thermal-Aid hot and cold pain management modality products, which also include the Thermal-Aid Zoo and the Thermal-Aid Headache Relief System. Med-X, Inc. also supports the fast-paced emerging cannabis industry through the Company's digital magazine, The Marijuana Times, which publishes high quality media content for the business, medical and legislative cannabis communities to generate revenue from advertisers as well as sell industry related merchandise to consumers. The Company has been involved in product development for a number of years and is ready to bring various non-psychoactive Cannabidiol products to the pain management markets, as well as supplying its products to agricultural and ancillary services industries through its Nature-Cide cultivation division. For more information regarding Med-X, Inc. and its divisions, please visit www.medx-rx.com, www.pac-sh.com, Nature-Cide®, Thermal-Aid ® therapy packs, Thermal-Aid Zoo, Thermal-Aid Headache Relief System, Nature-Cide Cannabis Division, The Marijuana Times or email firstname.lastname@example.org or call 818-349-2870.
No Offer or Solicitation Securities
This communication is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. There may be statements in this communication that are, or could be, "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and, therefore, subject to risks and uncertainties, including, but not limited to, statements regarding Med-X, Inc. or the combined company's future financial position, sales, costs, earnings, cash flows, other measures of results of operations, capital expenditures or debt levels are forward-looking statements. Words such as "may," "will," "expect," "intend," "estimate," "anticipate," "believe," "should," "forecast," "project" or "plan" or terms of similar meaning are also generally intended to identify forward-looking statements. Med-X, Inc. cautions that these statements are subject to numerous important risks, uncertainties, assumptions and other factors, some of which are beyond Med-X, Inc.'s control, that could cause Med-X, Inc. or the combined company's actual results to differ materially from those expressed or implied by such forward-looking statements. To learn more about the Risk factors, please review Med-X, Inc.'s Regulation A+ Offering Circular.
Contact Information: Med-X, Inc. 8236 Remmet Ave, Canoga Park, California 91304 (818) 349-2870